Skip to main content
. 2014 May;52(5):1322–1329. doi: 10.1128/JCM.00857-13

TABLE 3.

Discordant and reverse discordant isolates by antibiotic and study site

Antibiotic and discordancea No. (%) of isolatesb
IN MD PH SA
RIF
    Discordant isolates 4 (4.3) 3 (3.7) 6 (6.2) 3 (3.3)
    Total resistant isolates 92 (100.0) 81 (100.0) 97 (100.0) 92 (100.0)
    Reverse discordant isolates 0 1 (14.3) 4 (15.4) 0
    Total sensitive isolates 4 (100.0) 7 (100.0) 26 (100.0) 8 (100.0)
INH
    Discordant isolates 9 (9.8) 0 17 (16.7) 3 (3.2)
    Total resistant isolates 92 (100.0) 81 (100.0) 102 (100.0) 93 (100.0)
    Reverse discordant isolates 4 (100.0) 1 (14.3) 7 (33.3) 0
    Total sensitive isolates 4 (100.0) 7 (100.0) 21 (100.0) 7 (100.0)
FQL
    Discordant isolates 10 (10.9) 19 (28.4) 19 (42.2) 7 (8.0)
    Total resistant isolates 92 (100.0) 67 (100.0) 45 (100.0) 88 (100.0)
    Reverse discordant isolates 0 8 (38.1) 2 (4.0) 0
    Total sensitive isolates 4 (100.0) 21 (100.0) 50 (100.0) 12 (100.0)
AMI
    Discordant isolates 19 (20.7) 5 (10.9) 5 (20.8) 8 (8.6)
    Total resistant isolates 92 (100.0) 46 (100.0) 24 (100.0) 93 (100.0)
    Reverse discordant isolates 0 25 (59.5) 1 (1.0) 0
    Total sensitive isolates 4 (100.0) 42 (100.0) 99 (100.0) 7 (100.0)
a

Resistance and sensitivity were determined by DST. RIF, rifampin; INH, isoniazid; FQL, fluoroquinolones; AMI, aminoglycosides.

b

IN, India; MD, Moldova; PH, Philippines; SA, South Africa.